This is something Infigen have canvassed before -disallowed/business/infigen-energy-exploring-options-to-realise-value-20160517-gowskv.html
At that time it had an enterprise value of around $1.3bn, compared to $900m today (including a $150m capital raising in 2017).
It faces a looming risk that if the value of LGCs craters eg due to Government whims or additional supply of renewable energy coming on line, a large chunk of its revenue simply disappears. The financial statements are opaque on the exact makeup of its revenue, but working backwards from an inventory value of $70 per LGC in FY2018 it seems that they are worth about 40% of the total. (The value of LGCs, at least as represented in the company's inventory, has held up reasonably well in recent years but is a factor entirely outside the company's control.)
In the "positive" scenario of a 5% overall increase in total price per GWh sold (power + LGCs), my estimate is that IFN makes $165m EBITDA and trades on a forward EV/EBITDA multiple of around 5.6x. Its free cash flow yield would be upwards of 25% if it doesn't embark on any significant expansions. Given the company's financial leverage, any slight positive re-rating by the market will result in huge share price appreciation. For example a forward EV/EBITDA of 8.0 on these figures would have its shares return to $1.
In an extreme "negative" scenario where an LGC is worth zero and there is no substantial energy price inflation, the company's EBITDA is approximately $50m and it is barely able to service its debt.
The real numbers will of course fall somewhere in the middle, and I'm waiting for its price to fall a bit further to cover for the downside risk before considering a buy.
- Forums
- ASX - By Stock
- Infigen for Sale
IFN
infragreen group limited
Add to My Watchlist
0.45%
!
$1.12

This is something Infigen have canvassed before -...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.12 |
Change
0.005(0.45%) |
Mkt cap ! $151.3M |
Open | High | Low | Value | Volume |
$1.11 | $1.12 | $1.11 | $177.4K | 158.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6000 | $1.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.20 | 54711 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6000 | 1.100 |
1 | 10000 | 1.080 |
1 | 30000 | 1.070 |
1 | 10000 | 1.060 |
1 | 20000 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.200 | 54711 | 2 |
1.210 | 21405 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
IFN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online